Cargando…
Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathway
Recent studies have suggested that liraglutide could have a potential function in improving non-alcoholic fatty liver disease (NAFLD); however, the underlying molecular mechanism remains unclear. The aim of the present study was to investigate the role of the AMP-activated protein kinase (AMPK)/ster...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665609/ https://www.ncbi.nlm.nih.gov/pubmed/26640549 http://dx.doi.org/10.3892/etm.2015.2741 |